Pavel Stejskal: pavel.stejskal@upol.cz
Hani Goodarzi: hani.goodarzi@ucsf.edu
Josef Srovnal: josef.srovnal@upol.cz
Marián Hajdúch: marian.hajduch@upol.cz
Laura J. van ’t Veer: laura.vantveer@ucsf.edu
Mark Jesus M. Magbanua: mark.magbanua@ucsf.edu
Journal ID (nlm-ta): Mol Cancer
Journal ID (iso-abbrev): Mol Cancer
Title:
Molecular Cancer
Publisher:
BioMed Central
(London
)
ISSN
(Electronic):
1476-4598
Publication date
(Electronic):
21
January
2023
Publication date PMC-release: 21
January
2023
Publication date Collection: 2023
Volume: 22
Electronic Location Identifier: 15
Affiliations
[1
]GRID grid.489334.1, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry,
Palacký University and University Hospital in Olomouc, ; Olomouc, 779 00 Czech Republic
[2
]GRID grid.266102.1, ISNI 0000 0001 2297 6811, Department of Biochemistry and Biophysics, , University of California San Francisco, ; San Francisco, CA 94158 USA
[3
]GRID grid.266102.1, ISNI 0000 0001 2297 6811, Department of Urology, , University of California San Francisco, ; San Francisco, CA 94158 USA
[4
]GRID grid.266102.1, ISNI 0000 0001 2297 6811, Department of Laboratory Medicine, , University of California San Francisco, ; 2340 Sutter Street, San Francisco, CA USA
Article
Publisher ID:
1710
DOI: 10.1186/s12943-022-01710-w
PMC ID: 9862574
PubMed ID: 36681803
SO-VID: 158027cc-a856-4680-9e7c-dee96fe66366
Copyright © © The Author(s) 2023
License:
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium
or format, as long as you give appropriate credit to the original author(s) and the
source, provide a link to the Creative Commons licence, and indicate if changes were
made. The images or other third party material in this article are included in the
article's Creative Commons licence, unless indicated otherwise in a credit line to
the material. If material is not included in the article's Creative Commons licence
and your intended use is not permitted by statutory regulation or exceeds the permitted
use, you will need to obtain permission directly from the copyright holder. To view
a copy of this licence, visit
http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (
http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a
credit line to the data.
Funded by: Ministry of Health of the Czech Republic
Award ID: NV18-03-00470
Award ID: NV18-03-00470
Award ID: NV18-03-00470
Funded by: Ministry of Education, Youth and Sport of the Czech Republic
Award ID: LM2018132
Award ID: LM2018132
Award ID: LM2018132
Funded by: European Union - Next Generation EU
Award ID: LX22NPO5102
Award ID: LX22NPO5102
Award ID: LX22NPO5102
Funded by: FundRef http://dx.doi.org/10.13039/501100008530, European Regional Development Fund;
Award ID: ACGT CZ.02.1.01/0.0/0.0/16_026/0008448
Award ID: ACGT CZ.02.1.01/0.0/0.0/16_026/0008448
Award ID: ACGT CZ.02.1.01/0.0/0.0/16_026/0008448
Funded by: Era of Hope Scholar
Award ID: W81XWH-2210121
Funded by: The National Institutes of Health
Award ID: R01CA240984
Award ID: R01 CA255442
Award ID: R01 CA255442
Funded by: FundRef http://dx.doi.org/10.13039/100001006, Breast Cancer Research Foundation;
Award ID: BCRF-20-142
Funded by: Cancer Cell Mapping Initiative
Award ID: U54 CA274502
Funded by: UCSF Breast Oncology Program Research Development Award, and the Cancer Cell Mapping
Initiative
Award ID: 7030559